Email this article Progressive prostate cancer with metastasis in the urethra: clinical case
- Authors: Kеln A.A.1,2,3, Alifov D.G.1, Ratobolskikh A.V.1,2, Zasorina M.A.1, Volynkina L.V.2, Kupchin A.V.2,3, Novoselov V.G.3, Vayradyan A.V.2,3, Shvedskiy M.S.1
-
Affiliations:
- Tyumen State Medical University, Ministry of Health of Russia
- Multispecialty Clinical Medical Center “Medical City”
- Regional Urological Center, “Neftyannik”
- Issue: Vol 18, No 4 (2022)
- Pages: 136-140
- Section: CLINICAL NOTES
- Published: 03.12.2022
- URL: https://oncourology.abvpress.ru/oncur/article/view/1564
- DOI: https://doi.org/10.17650/1726-9776-2022-18-4-136-140
- ID: 1564
Cite item
Full Text
Abstract
Prostate cancer metastases are a major cause of death among men. Almost all men who died from prostate cancer previously had metastases to the bones or other sites, including the lymph nodes, lung, and liver. Urethral metastases are one of the rarest locations of prostate cancer metastases. In this clinical case, we present a case of a man who had a recurrence of prostatic adenocarcinoma 36 months after radical prostatectomy; diagnosis and treatment of the patient are described.
Keywords
About the authors
A. A. Kеln
Tyumen State Medical University, Ministry of Health of Russia;Multispecialty Clinical Medical Center “Medical City”;
Regional Urological Center, “Neftyannik”
Author for correspondence.
Email: artyom-keln@yandex.ru
ORCID iD: 0000-0002-5071-0604
Artem Aleksandrovich Kеln
54 Odesskaya St., Tyumen 625023;
32 Barnaul’skaya St., Tyumen 625000;
8/1 Yuriya Semovskykh St., Tyumen 625000
D. G. Alifov
Tyumen State Medical University, Ministry of Health of Russia
ORCID iD: 0000-0003-2504-8353
54 Odesskaya St., Tyumen 625023
Russian FederationA. V. Ratobolskikh
Tyumen State Medical University, Ministry of Health of Russia;Multispecialty Clinical Medical Center “Medical City”
ORCID iD: 0000-0002-9112-1099
54 Odesskaya St., Tyumen 625023;
32 Barnaul’skaya St., Tyumen 625000;
M. A. Zasorina
Tyumen State Medical University, Ministry of Health of Russia
ORCID iD: 0000-0002-5347-9970
54 Odesskaya St., Tyumen 625023
Russian FederationL. V. Volynkina
Multispecialty Clinical Medical Center “Medical City”
32 Barnaul’skaya St., Tyumen 625000
Russian FederationA. V. Kupchin
Multispecialty Clinical Medical Center “Medical City”;Regional Urological Center, “Neftyannik”
ORCID iD: 0000-0002-0818-8621
32 Barnaul’skaya St., Tyumen 625000;
8/1 Yuriya Semovskykh St., Tyumen 625000
V. G. Novoselov
Regional Urological Center, “Neftyannik”
8/1 Yuriya Semovskykh St., Tyumen 625000
Russian FederationA. V. Vayradyan
Multispecialty Clinical Medical Center “Medical City”;Regional Urological Center, “Neftyannik”
32 Barnaul’skaya St., Tyumen 625000;
8/1 Yuriya Semovskykh St., Tyumen 625000
M. S. Shvedskiy
Tyumen State Medical University, Ministry of Health of Russia
ORCID iD: 0000-0002-8854-2773
54 Odesskaya St., Tyumen 625023
Russian FederationReferences
- Rawla P. Epidemiology of prostate cancer. World J Oncol 2019;10(2):63–89. doi: 10.14740/wjon1191
- Litwin M.S., Tan H.J. The diagnosis and treatment of prostate cancer: a review. JAMA 2017;317(24):2532–42. doi: 10.1001/jama.2017.7248
- Keln A.A., Alifov D.G., Kupchin A.V. Improvement of screening programs for early detection of prostate cancer. Akademicheskiy zhurnal Zapadnoy Sibiri = Academic Journal of West Siberia 2019;15(5 (82)):42–3. (In Russ.).
- Holm H.V., Dahl A.A., Klepp O.H., Fosså S.D. Modern treatment of metastatic prostate cancer. Tidsskr Nor Laegeforen 2017;137(11):803–5. doi: 10.4045/tidsskr.16.0265
- Eng T.Y., Chen T.W., Patel A.J. et al. Treatment and outcomes of primary urethra cancer. Am J Clin Oncol 2018;41(9):905–8. doi: 10.1097/COC.0000000000000391
- Aydin F. Endometrioid adenocarcinoma of prostatic urethra presenting with anterior urethral implantation. Urology 1993;41(1):91–5. doi: 10.1016/0090-4295(93)90255-9
- Taylor G.B., McNeal J.E., Cohen R.J. Intraductal carcinoma of the prostate metastatic to the penile urethra: a rare demonstration of two morphologic patterns of tumor growth. Pathology 1998;30(2):218–21. doi: 10.1080/00313029800169306
- Ohyama C., Takyu S., Yoshikawa K. et al. Adenocarcinoma arising from the prostatic duct mimicking transitional cell carcinoma. Int J Urol 2001;8(7):408–11. doi: 10.1046/j.1442-2042.2001.00323.x
- Green J.M., Tang W.W., Jensen B.W., Orihuela E. Isolated recurrence of ductal prostate cancer to anterior urethra. Urology 2006;68(2):428.e13–5. doi: 10.1016/j.urology.2006.03.024
- Dong X., Wang L., Taniguchi K. et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003;72(2):270–80. doi: 10.1086/346094
- Stolarova L., Kleiblova P., Janatova M. et al. CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate. Cells 2020;9(12):2675. doi: 10.3390/cells9122675
- Isaacsson Velho P., Silberstein J.L., Markowski M.C. et al. Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA-repair gene mutations in prostate cancer. Prostate 2018;78(5):401–7. doi: 10.1002/pros.23484
- Giri V.N., Hegarty S.E., Hyatt C. et al. Germline genetic testing for inherited prostate cancer in practice: implications for genetic testing, precision therapy, and cascade testing. Prostate 2019;79(4):333–9. doi: 10.1002/pros.23739
- Wu Y., Yu H., Zheng S.L. et al. A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer. Prostate 2018;78(8):607–15. doi: 10.1002/pros.23505
- Yadav S., Hu C., Hart S.N. et al. Evaluation of germline genetic testing criteria in a hospital-based series of women with breast cancer. J Clin Oncol 2020;38(13):1409–18. doi: 10.1200/JCO.19.02190
Supplementary files
